Literature DB >> 8778165

Modifications of biochemical markers of bone and collagen turnover during corticosteroid therapy.

A Conti1, A Sartorio, S Ferrero, S Ferrario, B Ambrosi.   

Abstract

Serum bone Gla protein (BGP), carboxyterminal cross-linked telopeptide of type I collagen (ICTP) and aminoterminal propeptide of type III procollagen (PIIINP) levels were determined in 8 patients with autoimmune disorders (2 with systemic lupus erythematosus, 3 with rheumatoid arthritis, 2 with Sjögren's syndrome and 1 with mixed connective tissue disease) before and after 1, 2 and 4 months of treatment with oral prednisone (at a dosage of 1 mg/kg bw/day, p.o. during the first month, then reduced to 0.1-0.2 mg/kg bw/day). Before treatment mean serum BGP (mean +/- SE: 5.3 +/- 0.4 ng/ml) and ICTP (2.8 +/- 0.2 ng/ml) levels were similar to those recorded in an age and sex matched control group (n = 40: 5.4 +/- 0.1 ng/ml and 4.1 +/- 0.3 ng/ml, respectively). On the other hand, serum PIIINP levels (2.2 +/- 0.3 ng/ml) were significantly (p < 0.008) lower than those found in controls (3.3 +/- 0.2 ng/ml). During glucocorticoid therapy, serum BGP levels significantly decreased after 1 month (2.9 +/- 0.4 ng/ml; P < 0.001), but returned to baseline values after 2 and 4 months of treatment (4.7 +/- 0.4 ng/ml and 5.3 +/- 0.3 ng/ml, respectively). On the contrary, no significant changes were observed in serum ICTP levels during treatment (1st month: 2.7 +/- 0.4 ng/ml; 2nd month: 3.0 +/- 0.4 ng/ml; 4th month: 2.4 +/- 0.3 ng/ml). Serum PIIINP mean concentration significantly decreased after 1 (1.6 +/- 0.3 ng/ml; P < 0.004) and 2 months of glucocorticoid administration (1.5 +/- 0.2 ng/ml; P < 0.01); after 4 months, serum PIIINP levels were again reduced as before therapy (1.8 +/- 0.2 ng/ml). In conclusion, our study shows the presence of normal bone turnover indexes and of altered collagen synthesis in patients with autoimmune disorders. The use of high doses of oral steroids is associated with a prompt decrease of bone formation and collagen synthesis, without any significant changes in bone resorption; however, the negative effects on bone formation and collagen synthesis seem to revert after lowering corticosteroid dosage. Serial determinations of the markers of bone and collagen turnover are able to give useful and reliable information on the peripheral effects of steroids excess.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8778165     DOI: 10.1007/BF03349848

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  23 in total

1.  Bone turnover during high dose inhaled corticosteroid treatment.

Authors:  N J Ali; S Capewell; M J Ward
Journal:  Thorax       Date:  1991-03       Impact factor: 9.139

Review 2.  Glucocorticoid-induced osteoporosis: pathogenesis and management.

Authors:  B P Lukert; L G Raisz
Journal:  Ann Intern Med       Date:  1990-03-01       Impact factor: 25.391

3.  New markers of bone and collagen turnover in children and adults with growth hormone deficiency.

Authors:  A Sartorio; A Conti; M Monzani
Journal:  Postgrad Med J       Date:  1993-11       Impact factor: 2.401

4.  Effects of prednisone and deflazacort on mineral metabolism and parathyroid hormone activity in humans.

Authors:  C Gennari; B Imbimbo; M Montagnani; M Bernini; P Nardi; L V Avioli
Journal:  Calcif Tissue Int       Date:  1984-05       Impact factor: 4.333

5.  Serum bone Gla protein and carboxyterminal cross-linked telopeptide of type I collagen in patients with Cushing's syndrome.

Authors:  A Sartorio; A Conti; S Ferrario; E Passini; T Re; B Ambrosi
Journal:  Postgrad Med J       Date:  1996-07       Impact factor: 2.401

6.  Bone studies in patients on prolonged systemic corticosteroid therapy for asthma.

Authors:  P A Greenberger; R W Hendrix; R Patterson; J S Chmiel
Journal:  Clin Allergy       Date:  1982-07

7.  Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD).

Authors:  I R Reid; A R King; C J Alexander; H K Ibbertson
Journal:  Lancet       Date:  1988-01-23       Impact factor: 79.321

8.  Biochemical markers of bone and collagen turnover in acromegaly or Cushing's syndrome.

Authors:  A Piovesan; M Terzolo; G Reimondo; A Pia; A Codegone; G Osella; A Boccuzzi; P Paccotti; A Angeli
Journal:  Horm Metab Res       Date:  1994-05       Impact factor: 2.936

9.  Measures of bone loss in rheumatoid arthritis.

Authors:  M H Weisman; R W Orth; B D Catherwood; S C Manolagas; L J Deftos
Journal:  Arch Intern Med       Date:  1986-04

Review 10.  [Biological markers of bone metabolism].

Authors:  P D Delmas
Journal:  Presse Med       Date:  1993-02-20       Impact factor: 1.228

View more
  7 in total

1.  The impact of corticosteroids on growth and bone health.

Authors:  T Mushtaq; S F Ahmed
Journal:  Arch Dis Child       Date:  2002-08       Impact factor: 3.791

2.  Lower P1NP serum levels: a predictive marker of bone loss after 1 year follow-up in premenopausal systemic lupus erythematosus patients.

Authors:  L P C Seguro; C B Casella; V F Caparbo; R M Oliveira; A Bonfa; E Bonfa; R M R Pereira
Journal:  Osteoporos Int       Date:  2014-08-22       Impact factor: 4.507

3.  Long-term monitoring of rec-GH treatment by serial determination of serum aminoterminal propeptide of type III procollagen in children and adults with GH deficiency.

Authors:  A Sartorio; M Arosio; A Conti; S Ferrero; S Porretti; G Faglia
Journal:  J Endocrinol Invest       Date:  1999-03       Impact factor: 4.256

4.  Effect of single doses of dexamethasone and adrenocorticotrop hormone on serum bone markers in healthy subjects and in patients with adrenal incidentalomas and Cushing's syndrome.

Authors:  J Majnik; N Szücs; A Patócs; M Tóth; K Balogh; I Varga; E Gláz; K Rácz
Journal:  J Endocrinol Invest       Date:  2004-09       Impact factor: 4.256

5.  Evaluation of bone remodeling with (18)F-fluoride and correlation with the glucose metabolism measured by (18)F-FDG in lumbar spine with time in an experimental nude rat model with osteoporosis using dynamic PET-CT.

Authors:  Caixia Cheng; Christian Heiss; Antonia Dimitrakopoulou-Strauss; P Govindarajan; G Schlewitz; Leyun Pan; Reinhard Schnettler; Klaus Weber; Ludwig G Strauss
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-03-08

6.  Vitamin D deficiency in patients with active systemic lupus erythematosus.

Authors:  V Z C Borba; J G H Vieira; T Kasamatsu; S C Radominski; E I Sato; M Lazaretti-Castro
Journal:  Osteoporos Int       Date:  2008-07-04       Impact factor: 4.507

Review 7.  Circulating markers of bone turnover.

Authors:  Marc G Vervloet; Vincent M Brandenburg
Journal:  J Nephrol       Date:  2017-05-13       Impact factor: 3.902

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.